Japan Society of Clinical Oncology provisional clinical opinion for the diagnosis and use of immunotherapy in patients with deficient DNA mismatch repair tumors, cooperated by Japanese Society of Medical Oncology, First Edition

BACKGROUND: Novel therapeutic agents have improved survival outcomes in patients with advanced solid tumors. In parallel, the development of predictive biomarkers to identify patients who are likely to benefit from a certain treatment has also contributed to the improvement of survival. Recently, cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Mishima, Saori, Taniguchi, Hiroya, Akagi, Kiwamu, Baba, Eishi, Fujiwara, Yutaka, Hirasawa, Akira, Ikeda, Masafumi, Maeda, Osamu, Muro, Kei, Nishihara, Hiroshi, Nishiyama, Hiroyki, Takano, Tadao, Tsuchihara, Katsuya, Yatabe, Yasushi, Kodera, Yasuhiro, Yoshino, Takayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2019
Materias:
Special Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989445/
https://www.ncbi.nlm.nih.gov/pubmed/31286289
http://dx.doi.org/10.1007/s10147-019-01498-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989445/
https://www.ncbi.nlm.nih.gov/pubmed/31286289
http://dx.doi.org/10.1007/s10147-019-01498-8

Ejemplares similares